Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03534323
Title Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami- Sylvester Comprehensive Cancer Center ACTIVE_NOT_RECRUITING Miami Florida 33136 United States Details
Northern Light Eastern Maine Medical Center RECRUITING Brewer Maine 04412 United States Details
Massachusetts General Hospital ACTIVE_NOT_RECRUITING Boston Massachusetts 02114 United States Details
Boston Medical Center COMPLETED Boston Massachusetts 02118 United States Details
Beth Israel Deaconess Medical Center COMPLETED Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Berkshire Medical Center COMPLETED Pittsfield Massachusetts 01201 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field